Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
89
天
Tumor-intrinsic PHGDH inhibition sensitizes colorectal cancer to PD-1 blockade via α-ketoglutarate–mediated macrophage reprogramming
作者
Jieping Qiu; Jingwen Wei; Jiaming Liu; Jing Bai; Keqin Tan; Yuhao Wei; Haorui Zhou; Lusi Feng; Qianlong Kang; Huan Tong; Yuting Jiang; Yu Zhang; Jiaqing Yang; Xiaoqian Yang; Qin Zhang; Jingsi Dong; Yuwen Zhou; Xuelei Ma展开收起
作者单位
Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Department of Postgraduate students, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Department of Colorectal Cancer Center, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China展开收起
73
天
ITPKB suppresses ER calcium release to promote CXCL9 expression and enhance immunotherapy sensitivity in triple-negative breast cancer
作者
Kejing Zhang; Xia Wang; Qiaoli Yi; Huajie Guan; Jiayu Wang; Fengyu Tan; Zhiyang Zhou; Xudong Zhu; Cheng Zhan; Jin Wang; Jianmin Wu; Hailin Tang; Zhijie Xu; Zeyu Shuang; Yuanliang Yan展开收起
作者单位
Department of Pharmacy, National Clinical Research Center for Geriatric Diseases (Xiangya Hospital of Central South University), The Hunan Institute of Pharmacy Practice and Clinical Research, Xiangya Hospital, Central South University, Changsha 410008, China; Department of General Surgery, Xiangya Hospital, Central South University, Changsha 410008, China; Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China; Markey Cancer Center, University of Kentucky, Lexington, KY 40536, USA; Department of Thoracic Surgery, Cancer Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China展开收起
223
天
Targeting a novel metabolic vulnerability of non-small cell lung cancer to fatty acid oxidation surmounts chemoresistance
作者
Simona Fontana; Dimas Carolina Belisario; Claudia Giannotta; Luca Alessandri; Sabrina Digiovanni; Angelo Meoli; Francesco Passiglia; Alessandra Merlini; Giulianmichela Di Palma; Martina Perin; Francesca Napoli; Maddalena Arigoni; Muhlis Akman; Elisa Balmas; Costanzo Costamagna; Iris Chiara Salaroglio; Joanna Kopecka; Alessandro Bertero; Luisella Righi; Massimo Massaia; Raffaele Calogero; Silvia Novello; Giorgio Vittorio Scagliotti; Yehuda G. Assaraf; Chiara Riganti展开收起
作者单位
Department of Oncology, University of Torino, Torino, Italy; Molecular Biotechnology Center “Guido Tarone”, University of Torino, Torino, Italy; Candiolo Cancer Institute, Fondazione del Piemonte per l’Oncologia-IRCCS, Candiolo, Italy; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy; Medical Oncology Unit, Department of Oncology at AOU San Luigi Hospital, Orbassano, Italy; Pathology Unit, Department of Oncology at AOU San Luigi Hospital, Orbassano, Italy; Neuroscience Unit, Bahcesehir University, Istanbul, Turkey; Division of Hematology, AO Santa Croce e Carle, Cuneo, Italy; The Fred Wyszkowski Cancer Research Laboratory, Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel展开收起
57
天
MZF1-mediated GAPDH overexpression drives glycolytic reprogramming and neuroendocrine progression in advanced prostate cancer
作者
Wang Liu; Lily He; Cuncong Zhong; Yuzhuo Wang; Da Zhang; Moben Mirza; Benyi Li展开收起
作者单位
Departments of Urology, The University of Kansas Medical Center, Kansas City, KS 66160, USA; Departments of Pathology & Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS 66160, USA; Department of Electrical Engineering & Computer Science, The University of Kansas School of Engineering, Lawrence, KS 66045, USA; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver V5Z 1M9, Canada展开收起
219
天
ZBED6-driven nucleotide metabolic reprogramming improves sensitivity to anti-PD1 therapy in NK/T cell lymphoma
作者
Cailu Song; Wenjian Liu; Xiaofang Xie; Cheng Peng; Lewei Zhu; Lingrui Liu; Yutian Zou; Xiaoming Xie; Hailin Tang; Jia Zhu; Chengcheng Liu; Hua Wang展开收起
作者单位
State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China; Chinese Medicine Germplasm Resources Innovation and Effective Uses Key Laboratory of Sichuan Province, State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China; The First People's Hospital of Foshan (Foshan Hospital Affiliated to Southern University of Science and Technology), School of Medicine, Southern University of Science and Technology, Foshan, Guangdong, China; Department of Hematology, The Third Affiliated Hospital of Sun Yat-Sen University; Institute of Hematology, Sun Yat-sen University, Guangzhou , Guangdong , China展开收起
122
天
Protein SUMOylation confers sorafenib resistance in human hepatocellular carcinoma via the induction of PKM2-mediated glycolysis
作者
Hongchao Yuan; Yuanjun Lu; Zhuofeng Jiang; Yau-Tuen Chan; Junyu Wu; Zixin Feng; Lin Xu; Qiucheng Li; Pengde Lu; Chun-Fung Kwok; Tung-Leong Fong; Qinguo Huang; Liuya Wei; Yibin Feng; Zhe-Sheng Chen; Ning Wang展开收起
作者单位
School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, 3 Sassoon Road, Pokfulam, Hong Kong; Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China; Laboratory for Synthetic Chemistry and Chemical Biology Limited, Hong Kong Science Park, Hong Kong; Department of Neurosurgery, The Second Affiliated Hospital, Shantou University Medical College, Shantou, China; School of Pharmacy, Shandong Second Medical University, Weifang, Shandong, China; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, USA; Department of Chinese Medicine, the University of Hong Kong–Shenzhen Hospital (HKU-SZH), Shenzhen, China展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天